Hot Features
프리미엄
Aerovate Therapeutics Inc (AVTE)
NASDAQ
같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. 더 보기
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024 NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 0.78431372549 | 2.55 | 2.7 | 2.44 | 292448 | 2.54432736 | CS |
| 4 | -0.14 | -5.16605166052 | 2.71 | 2.71 | 2.4 | 271898 | 2.53336202 | CS |
| 12 | -0.11 | -4.10447761194 | 2.68 | 2.73 | 2.4 | 233053 | 2.57940672 | CS |
| 26 | 0.939 | 57.5720416922 | 1.631 | 3 | 1.61 | 493611 | 2.39722444 | CS |
| 52 | -14.87 | -85.2637614679 | 17.44 | 32.415 | 1.25 | 575383 | 4.35091332 | CS |
| 156 | -6.59 | -71.943231441 | 9.16 | 32.415 | 1.25 | 250854 | 7.67909564 | CS |
| 260 | -25.43 | -90.8214285714 | 28 | 32.415 | 1.25 | 227489 | 8.38163344 | CS |
